216 related articles for article (PubMed ID: 31120964)
1. Subcellular compartmentalization of PKM2 identifies anti-PKM2 therapy response in vitro and in vivo mouse model of human non-small-cell lung cancer.
Suzuki A; Puri S; Leland P; Puri A; Moudgil T; Fox BA; Puri RK; Joshi BH
PLoS One; 2019; 14(5):e0217131. PubMed ID: 31120964
[TBL] [Abstract][Full Text] [Related]
2. Targeting pyruvate kinase M2 contributes to radiosensitivity of non-small cell lung cancer cells in vitro and in vivo.
Meng MB; Wang HH; Guo WH; Wu ZQ; Zeng XL; Zaorsky NG; Shi HS; Qian D; Niu ZM; Jiang B; Zhao LJ; Yuan ZY; Wang P
Cancer Lett; 2015 Jan; 356(2 Pt B):985-93. PubMed ID: 25444918
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of the M2 Isoform of Pyruvate Kinase (PKM2) with shRNA Enhances the Effect of Docetaxel in Human NSCLC Cell Lines In Vitro.
Yuan S; Qiao T; Zhuang X; Chen W; Xing N; Zhang Q
Yonsei Med J; 2016 Nov; 57(6):1312-23. PubMed ID: 27593857
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model.
Guo W; Zhang Y; Chen T; Wang Y; Xue J; Zhang Y; Xiao W; Mo X; Lu Y
J Cancer Res Clin Oncol; 2011 Jan; 137(1):65-72. PubMed ID: 20336315
[TBL] [Abstract][Full Text] [Related]
5. Apoptin Inhibits Glycolysis and Regulates Autophagy by Targeting Pyruvate Kinase M2 (PKM2) in Lung Cancer A549 Cells.
Song G; Shang C; Zhu Y; Xiu Z; Li Y; Yang X; Ge C; Han J; Jin N; Li Y; Li X; Fang J
Curr Cancer Drug Targets; 2024; 24(4):411-424. PubMed ID: 36284386
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of PKM2 Enhances Radiosensitivity of Non-small cell Lung Cancer.
Wang S; Ma Y; Wang P; Song Z; Liu B; Sun X; Zhang H; Yu J
Cell Biochem Biophys; 2015 Sep; 73(1):21-6. PubMed ID: 25649613
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of SR splicing-factor 5 knockdown by downregulating pyruvate kinase M2 in non-small cell lung cancer cells.
Yan J; Zhang D; Han Y; Wang Z; Ma C
J Cell Biochem; 2019 Oct; 120(10):17303-17311. PubMed ID: 31106485
[TBL] [Abstract][Full Text] [Related]
8. Enhancing 5-fluorouracil efficacy through suppression of PKM2 in colorectal cancer cells.
Cao Y; Lin Y; Wang D; Pan D; Zhang Y; Jin Y; Zheng C
Cancer Chemother Pharmacol; 2018 Dec; 82(6):1081-1086. PubMed ID: 30155759
[TBL] [Abstract][Full Text] [Related]
9. TIPE3 differentially modulates proliferation and migration of human non-small-cell lung cancer cells via distinct subcellular location.
Wang G; Guo C; Zhao H; Pan Z; Zhu F; Zhang L; Wang Q
BMC Cancer; 2018 Mar; 18(1):260. PubMed ID: 29510688
[TBL] [Abstract][Full Text] [Related]
10. Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2.
Cai F; Zhu Q; Miao Y; Shen S; Su X; Shi Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):59-69. PubMed ID: 27629878
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of miR-214 inhibits proliferation and glycolysis in non-small-cell lung cancer cells via down-regulating the expression of hexokinase 2 and pyruvate kinase isozyme M2.
Zhang K; Zhang M; Jiang H; Liu F; Liu H; Li Y
Biomed Pharmacother; 2018 Sep; 105():545-552. PubMed ID: 29886375
[TBL] [Abstract][Full Text] [Related]
12. Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice.
Shi HS; Li D; Zhang J; Wang YS; Yang L; Zhang HL; Wang XH; Mu B; Wang W; Ma Y; Guo FC; Wei YQ
Cancer Sci; 2010 Jun; 101(6):1447-53. PubMed ID: 20507318
[TBL] [Abstract][Full Text] [Related]
13. PKM2 Knockdown Induces Autophagic Cell Death via AKT/mTOR Pathway in Human Prostate Cancer Cells.
Dey P; Kundu A; Sachan R; Park JH; Ahn MY; Yoon K; Lee J; Kim ND; Kim IS; Lee BM; Kim HS
Cell Physiol Biochem; 2019; 52(6):1535-1552. PubMed ID: 31135122
[TBL] [Abstract][Full Text] [Related]
14. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
15. [Antitumor effect by combination of shRNA interfering plasmid targeting PKM2 with recombinant endostatin].
Mao JZ; Guo WH; Shi HS; Zhao YW; Yang HS
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 May; 42(3):308-12. PubMed ID: 21826988
[TBL] [Abstract][Full Text] [Related]
16. Silencing survivin expression inhibits the tumor growth of non-small-cell lung cancer cells in vitro and in vivo.
Zhang K; Li Y; Liu W; Gao X; Zhang K
Mol Med Rep; 2015 Jan; 11(1):639-44. PubMed ID: 25333812
[TBL] [Abstract][Full Text] [Related]
17. Natural product fargesin interferes with H3 histone lactylation via targeting PKM2 to inhibit non-small cell lung cancer tumorigenesis.
Guo Z; Tang Y; Wang S; Huang Y; Chi Q; Xu K; Xue L
Biofactors; 2024; 50(3):592-607. PubMed ID: 38149461
[TBL] [Abstract][Full Text] [Related]
18. Aldolase A promotes proliferation and G
Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation.
Hsieh FS; Hung MH; Wang CY; Chen YL; Hsiao YJ; Tsai MH; Li JR; Chen LJ; Shih CT; Chao TI; Chen KF
Lung Cancer; 2017 Oct; 112():81-89. PubMed ID: 29191605
[TBL] [Abstract][Full Text] [Related]
20. Metastasis-Associated 1 (MTA1) Gene Expression Promotes Angiogenesis in Mouse Xenografts from Human Non-Small Cell Lung Cancer (NSCLC) Cells.
Wang T; Li W; Huang H; Wang C
Med Sci Monit; 2019 Jan; 25():484-491. PubMed ID: 30651530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
